SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000947871-18-000868
Filing Date
2018-11-01
Accepted
2018-11-01 16:10:25
Documents
2
Group Members
ORBIMED ADVISORS ISRAEL II LTDORBIMED CAPITAL GP VI LLCORBIMED ISRAEL GP II, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss113236_sc13d.htm SC 13D 164261
2 JOINT FILING AGREEMENT ss113236_ex9901.htm EX-99.1 20882
  Complete submission text file 0000947871-18-000868.txt   186740
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address 700 MAIN STREET CAMBRIDGE MA 02139
Business Address 700 MAIN STREET CAMBRIDGE MA 02139 61(0)428-338-594
LogicBio Therapeutics, Inc. (Subject) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90696 | Film No.: 181153860
SIC: 2836 Biological Products, (No Diagnostic Substances)